Tecan slides as it confirms mid-term guidance

** Shares in Tecan TECN fall 5.4% after the laboratory instruments provider maintained its mid-term outlook and posted its Q3 results

** The weak reaction is "in light of the confirmed specified sales guidance," analysts at UBS say

** UBS adds that the guidance implies mid-single-digit downside to current 2025 EPS consensus estimates

** Vontobel analysts see 2025 and now also 2026 as transitional years, adding that sentiment on the stock remains mixed

** Shares undeperform pan-European SXXP, which is up 0.4%